Barbara Jezeršek Novaković

The predictive significance of CD20 expression in B-cell lymphomas

Veronika Kloboves Prevodnik, Jaka Lavrenčak, Mateja Horvat et al. · Diagnostic Pathology · 2011 · 78 citations · Full text

Diffuse large B-cell lymphoma: 10�years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Matej Horvat, Vesna Zadnik, Tanja Južnič Šetina et al. · Oncology Letters · 2018 · 53 citations · Full text

Population pharmacokinetics of rituximab in patients with diffuse large B‐cell lymphoma and association with clinical outcome

Samo Rožman, Iztok Grabnar, Srdjan Novaković et al. · British Journal of Clinical Pharmacology · 2017 · 51 citations · Full text

Validation of Family History of Cancer in Deceased Family Members

Barbara Jezeršek Novaković, Alisa M. Goldstein, M. A. Tucker · JNCI Journal of the National Cancer Institute · 1996 · 42 citations · Full text

Family Medicine, Cancer Epidemiology, Family Members +13

Comparison of the algorithms classifying the ABC and GCB subtypes in diffuse large B-cell lymphoma

Lučka Boltežar, Veronika Kloboves Prevodnik, Maja Pohar Perme et al. · Oncology Letters · 2018 · 30 citations · Full text

Immunology, Pathology, Immunophenotyping +18